701232-20-4,
DGAT-3,
T863,
DGAT-1 inhibitor,
UNII-OF68Z8HK6V,
OF68Z8HK6V,
trans-4-[4-(4-Amino-7,7-dimethyl-7H-pyrimido[4,5-b][1,4]oxazin-6-yl)phenyl]cyclohexaneacetic acid,
T-863,
2-(4-(4-(4-amino-7,7-dimethyl-7H-pyrimido[4,5-b][1,4]oxazin-6-yl)phenyl)cyclohexyl)acetic acid,
trans-4-(4-(4-amino-7,7-dimethyl-7h-pyrimido(4,5-b)(1,4)oxazin-6-yl)phenyl)cyclohexaneacetic acid,
2-[4-(4-{4-amino-7,7-dimethyl-7H-pyrimido[4,5-b][1,4]oxazin-6-yl}phenyl)cyclohexyl]acetic acid,
Cyclohexaneacetic acid, 4-(4-(4-amino-7,7-dimethyl-7H-pyrimido(4,5-b)(1,4)oxazin-6-yl)phenyl)-, trans-,
Cyclohexaneacetic acid, 4-[4-(4-amino-7,7-dimethyl-7H-pyrimido[4,5-b][1,4]oxazin-6-yl)phenyl]-, trans-,
701234-65-3,
CHEMBL473967,
GTPL7828,
SCHEMBL2501908,
SCHEMBL2501911,
SCHEMBL14463646,
SCHEMBL14463688,
SCHEMBL16624993,
BDBM27947,
AOB1607,
DTXSID50432079,
ZINC40901549,
AKOS032947278,
DGAT-1 inhibitor;T 863;T-863,
ZINC100073838,
ZINC147228368,
CS-0300,
RL04688,
NCGC00378678-01,
4CA-0454,
701236-77-3,
DA-04087,
HY-32219,
T863, >=98% (HPLC),
AJ-103833,
FT-0763494,
Y0346,
pyrimido[4,5-b][1,4]oxazine derivative, 2,
W-5503,
234C653,
J-525016,
{4-[4-(4-Amino-7,7-dimethyl-7H-pyrimido[4,5-b][1,4]oxazin-6-yl)phenyl]cyclohexyl}acetic acid,
2-[4-[4-(4-amino-7,7-dimethylpyrimido[4,5-b][1,4]oxazin-6-yl)phenyl]cyclohexyl]acetic acid,
cis-4-[4-(4-Amino-7,7-dimethyl-7H-pyrimido[4,5-b][1,4]oxazin-6-yl)phenyl]cyclohexaneacetic acid,
D02NRD,
cc-141,
FUIYMYNYUHVDPT-UHFFFAOYSA-N,
C22H26N4O3,
CID9865421,
CID 9865421,
cis-4-[4- phenyl]cyclohexaneaceticacid,
A3363,
Cyclohexaneacetic acid, 4-[4-(4-amino-7,7-dimethyl-7H-pyrimido[4,5-b][1,4]oxazin-6-yl)phenyl]-, cis-,
trans-4-[4-(4-Amino-7,7-dimethyl-7H-pyrimido[4,5-b][1,4]oxazin-6-yl)phenyl]-cyclohexaneacetic acid,